Climb Bio (CLYM) Earnings Date & Reports

Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CLYM is expected to report earnings to fall 41.94% to -18 cents per share on August 19

Q2'25

Est.

$-0.18

Q1'25

Missed

by $0.16

The last earnings report on May 14 showed earnings per share of -31 cents, missing the estimate of -15 cents. With 3.60M shares outstanding, the current market capitalization sits at 79.74M.

View a ticker or compare two or three

Compare

CLYM

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CLYM
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details